SCHEMBL17040898

SCHEMBL17040898

CC(C)(C)OC(=O)NC1(c2ccccc2)CCC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SSTR4 P31391 1/20 0.47
AKT1 P31749 2/20 0.46
AKT2 P31751 1/20 0.46
CNR1 P21554 2/20 0.43
CNR2 P34972 2/20 0.43
POLB P06746 1/20 0.41
TACR3 P29371 2/20 0.40
ROCK2 O75116 1/20 0.40
ROCK1 Q13464 1/20 0.40
HDAC3 O15379 1/20 0.40
HDAC1 Q13547 1/20 0.40
HDAC2 Q92769 1/20 0.40
HDAC6 Q9UBN7 1/20 0.40
KMT2A Q03164 2/20 0.40
MEN1 O00255 1/20 0.40
NPC1 O15118 1/20 0.40
GAA P10253 1/20 0.40
RAB9A P51151 1/20 0.40
CA12 O43570 1/20 0.40
CA1 P00915 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL89721 0.97 SSTR4 (0.50) SSTR4AKT1AKT2CNR1CNR2
SCHEMBL2554955 0.94 AKT1 (0.47) SSTR4AKT1AKT2CNR1CNR2
SCHEMBL12133598 0.89 AKT1 (0.45) SSTR4AKT1AKT2CNR1CNR2
SCHEMBL3892253 0.88 OPRM1 (0.45) SSTR4AKT1AKT2CNR1CNR2
SCHEMBL1534790 0.88 AKT1 (0.44) SSTR4AKT1AKT2CNR1CNR2
Hydrochloric Acid SCHEMBL27552695 0.87 OPRM1 (0.44) SSTR4AKT1AKT2CNR1CNR2
SCHEMBL2191957 0.87 MAPT (0.46) SSTR4AKT1AKT2CNR1CNR2
SCHEMBL1412064 0.87 CNR1 (0.44) SSTR4AKT1AKT2CNR1CNR2
SCHEMBL14161397 0.87 AKT1 (0.42) AKT1AKT2CNR1CNR2HDAC3
SCHEMBL16420447 0.86 CNR1 (0.47) AKT1AKT2CNR1CNR2POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020120606-A1 NEW PYRROLIDINE-2-CARBOXYLIC ACID DERIVATIVES FOR TREATING PAIN AND PAIN RELATED CONDITIONS ESTEVE PHARMACEUTICALS, S.A. (ES) 2020-06-18 WO disclosed
EP-3107900-B1 5-BENZYLISOQUINOLEINE DERIVATIVES FOR THE TREATMENT OF CARDIOVASCULAR DISEASES SERVIER LAB (FR) 2017-11-15 EP disclosed
CN-105315161-B The preparation method of the key intermediate of one class PKB/Akt inhibitor 厦门医学院 2017-08-04 CN disclosed
WO-2015124877-A1 DERIVATIVES OF 5-BENZYLISOQUINOLINE FOR THE TREATMENT OF CARDIOVASCULAR DISEASES LES LABORATOIRES SERVIER (FR) 2015-08-27 WO disclosed